Weekly Digests

2021

September

Dream team: TGFβ and PD-L1 targeting aligns with radiotherapy to create a beneficial immune environment

September 15, 2021

Since radiotherapy (RT) can boost immune priming, it can be a great tool to convert immune “cold” tumors into “hot” immune environments, making way for effective checkpoint inhibition therapies. However, RT may also remodel the tumor microenvironment (TME), creating barriers to immune infiltration and antitumor effects. Given that one of the main contributors...

Arming CARs with RNA to boost immune responses

September 8, 2021

Treatment of solid tumors with CAR T has various barriers to overcome to be effective. To improve efficacy, boosting the immune response by delivering pattern recognition receptor (PRR) agonists more specifically to immune than tumor cells might improve responses, given the known role of some PRRs to drive tumor progression. To do this, Johnson...

Tvax: A vaccine made from T cells

September 1, 2021

Therapeutic cancer vaccines consistently show great promise, but often fall short of expectations. Past studies have successfully used dendritic cells (DCs) to carry antigens to tumors, but DCs can be difficult to obtain and manipulate in large numbers. T cells, on the other hand, are readily available, easy to modify and expand (due...

Close Modal

Small change for you. Big change for us!

This Thanksgiving season, show your support for cancer research by donating your change.

In less than a minute, link your credit card with our partner RoundUp App.

Every purchase you make with that card will be rounded up and the change will be donated to ACIR.

All transactions are securely made through Stripe.